A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction

Clinical Genetics

Volumn 52, Issue 2, 1997, Pages 71-76

  Berge, K E ^a   Bakken, A ^b   Bohn M ^a   Erikssen, J ^c   Berg, Kåre ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin I; Angiotensin II type 1 receptor; Case control study; Converting enzyme; DNA; High risk group; Low risk group; Myocardial infarction; PCR; Polymorphism

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTILIPEMIC AGENT; APOLIPOPROTEIN B;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0030839391     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb02521.x     Document Type: Article

References (17)

1. Berg K. Twin studies of coronary heart disease and its risk factors. Acta Genet Med Gemellol 1984: 33: 349-361.
2. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994: 45: 169-174.
3. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993: 44: 292-297.
4. Bonnardeaux A, Davis E, Jeunemaitre X, Féry T, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994: 24: 63-69.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-M, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992: 359: 641-644.
6. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989: 165: 196-203.
7. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995: 112: 137-143.
8. Johnston CI. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens 1992: 10 (suppl 7): S13-S26.
9. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995: 345: 1600-1603.
10. Lindpaintner K, Pfeffer MA, Kreutz R, Stamfper MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995: 332: 706-711.
11. Mattu RK, Needham EWA, Gallon DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation 1995: 91: 270-274.
12. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in Japanese. Circulation 1994: 90: 2199-2202.
13. Nakauchi Y, Suehiro T, Yamamoto M, Yasuoka N, Arii K, Kumon Y, Hamashige N, Hashimoto K. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 1996: 125: 161-169.
14. Rolfs A, Weber-Rolfs I, Regitz-Zagrosek V, Kallisch H, Riedel K, Fleck E. Genetic polymorphisms of the angiotensin II type 1 (AT1) receptor gene. Eur Heart J 1994: 15 (suppl. D): 108-112.
15. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy, N Engl J Med 1994: 330: 1634-1638.
16. Siervogel RM, Morrison JA, Kelly K, Mellies M, Gartside P, Glueck CJ. Familial hyper-alpha-lipoproteinemia in 26 kindreds. Clin Genet 1980: 17: 13-25.
17. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetière P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994: 344: 910-913.